Editorial: The Role of Inhibitory Receptors in Inflammation and Cancer.
作者信息
Zarrin Ali A, Monteiro Renato C
机构信息
TRexBio, South San Francisco, CA, United States.
Center for Research on Inflammation, Université de Paris, Paris, France.
出版信息
Front Immunol. 2020 Dec 22;11:633686. doi: 10.3389/fimmu.2020.633686. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: The Role of Inhibitory Receptors in Inflammation and Cancer.社论：抑制性受体在炎症和癌症中的作用
Front Immunol. 2020 Dec 22;11:633686. doi: 10.3389/fimmu.2020.633686. eCollection 2020.
2
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.抑制性白细胞免疫球蛋白样受体：免疫检查点蛋白与肿瘤维持因子。
Cell Cycle. 2016;15(1):25-40. doi: 10.1080/15384101.2015.1121324.
3
Early signaling via inhibitory and activating NK receptors.通过抑制性和激活性自然杀伤细胞受体的早期信号传导。
Hum Immunol. 2000 Jan;61(1):51-64. doi: 10.1016/s0198-8859(99)00157-3.
4
Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells.基于免疫受体酪氨酸的抑制基序的受体调节基于免疫受体酪氨酸的激活基序诱导的免疫活性细胞的激活。
Immunol Lett. 1999 May 3;68(1):3-15. doi: 10.1016/s0165-2478(99)00024-3.
5
Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.树突状细胞免疫受体：抗原呈递细胞上用于模式识别和信号传导的C型凝集素受体。
J Dermatol Sci. 2007 Feb;45(2):77-86. doi: 10.1016/j.jdermsci.2006.09.001. Epub 2006 Oct 13.
6
Inhibitory ITAMs: a matter of life and death.抑制性免疫受体酪氨酸激活基序：生死攸关之事。
Trends Immunol. 2008 Aug;29(8):366-73. doi: 10.1016/j.it.2008.05.001. Epub 2008 Jul 2.
7
Platelet integrins and immunoreceptors.血小板整合素与免疫受体。
Immunol Rev. 2007 Aug;218:247-64. doi: 10.1111/j.1600-065X.2007.00532.x.
8
Inhibitory leukocyte immunoglobulin-like receptors in cancer development.癌症发展中的抑制性白细胞免疫球蛋白样受体
Sci China Life Sci. 2015 Dec;58(12):1216-25. doi: 10.1007/s11427-015-4925-1. Epub 2015 Nov 14.
9
The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering.诱导不依赖HLA-I类分子的自然杀伤（NK）细胞触发的人类自然细胞毒性受体（NCR）。
Hum Immunol. 2000 Jan;61(1):1-6. doi: 10.1016/s0198-8859(99)00162-7.
10
Function of killer cell inhibitory receptors for MHC class I molecules.MHC I类分子杀伤细胞抑制性受体的功能。
Immunol Lett. 1996 Dec;54(2-3):145-50. doi: 10.1016/s0165-2478(96)02664-8.
引用本文的文献
1
Mammalian Species-Specific Resistance to Mammary Cancer.哺乳动物对乳腺癌的物种特异性抗性。
J Mammary Gland Biol Neoplasia. 2025 Mar 6;30(1):3. doi: 10.1007/s10911-025-09578-4.
2
SIRPα engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolism.SIRPα 结合调节 ILC2 效应功能，并通过调节能量代谢减轻气道高反应性。
Cell Mol Immunol. 2024 Oct;21(10):1158-1174. doi: 10.1038/s41423-024-01208-z. Epub 2024 Aug 19.
3
Regulation of immune response against third-stage larvae by human genes.人体基因对第三期幼虫免疫反应的调控。
Front Immunol. 2023 Aug 3;14:1218965. doi: 10.3389/fimmu.2023.1218965. eCollection 2023.
4
New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.抗病毒治疗的新靶点：髓系细胞上的抑制性受体和免疫检查点。
Viruses. 2022 May 25;14(6):1144. doi: 10.3390/v14061144.
5
Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update.黑色素瘤治疗中对免疫检查点抑制剂耐药的分子机制：最新进展
Biomedicines. 2021 Jul 18;9(7):835. doi: 10.3390/biomedicines9070835.
6
PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.胆管癌中 B 细胞表达的 PNOC 与生存相关，而 LAIR2 可能是肿瘤微环境中 T 细胞耗竭的生物标志物：单细胞和批量测序技术联合分析免疫微环境。
Front Immunol. 2021 Mar 24;12:647209. doi: 10.3389/fimmu.2021.647209. eCollection 2021.
本文引用的文献
1
Inhibitory Receptor Trap: A Platform for Discovery of Inhibitory Receptors That Utilize Inositol Lipid and Phosphotyrosine Phosphatase Effectors.抑制性受体陷阱：一种用于发现利用肌醇脂质和磷酸酪氨酸磷酸酶效应物的抑制性受体的平台。
Front Immunol. 2020 Oct 21;11:592329. doi: 10.3389/fimmu.2020.592329. eCollection 2020.
2
IgG4-related disease: an update on pathophysiology and implications for clinical care.IgG4相关性疾病：病理生理学最新进展及其对临床治疗的意义
Nat Rev Rheumatol. 2020 Dec;16(12):702-714. doi: 10.1038/s41584-020-0500-7. Epub 2020 Sep 16.
3
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 T cell exhaustion.胶原通过 LAIR1 依赖性 CD8 T 细胞耗竭促进癌症对 PD-1/PD-L1 的耐药性。
Nat Commun. 2020 Sep 9;11(1):4520. doi: 10.1038/s41467-020-18298-8.
4
Functional categories of immune inhibitory receptors.免疫抑制受体的功能类别。
Nat Rev Immunol. 2020 Dec;20(12):771-780. doi: 10.1038/s41577-020-0352-z. Epub 2020 Jul 1.
5
Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease.配对免疫球蛋白样受体 2 型α G78R 变体改变配体结合并赋予阿尔茨海默病保护作用。
PLoS Genet. 2018 Nov 2;14(11):e1007427. doi: 10.1371/journal.pgen.1007427. eCollection 2018 Nov.
6
Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation.Lyn和Fyn作为分子开关，控制免疫受体以引导体内平衡或炎症反应。
Nat Commun. 2017 Aug 15;8(1):246. doi: 10.1038/s41467-017-00294-0.
7
Cancer immunotherapy targeting the CD47/SIRPα axis.靶向CD47/SIRPα轴的癌症免疫疗法。
Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10.
8
Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection.利什曼原虫利用巨噬细胞诱导性C型凝集素受体（Mincle）靶向树突状细胞中的一种抑制性免疫受体酪氨酸激活基序（ITAM）信号通路，该通路会抑制对感染的适应性免疫。
Immunity. 2016 Oct 18;45(4):788-801. doi: 10.1016/j.immuni.2016.09.012. Epub 2016 Oct 11.
9
Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.关于免疫受体酪氨酸抑制基序（ITIMs）、免疫受体酪氨酸激活基序（ITAMs）以及免疫受体酪氨酸激活基序类似物（ITAMis）：重新审视免疫球蛋白Fc受体信号传导
Immunol Rev. 2015 Nov;268(1):66-73. doi: 10.1111/imr.12336.
10
PILRα negatively regulates mouse inflammatory arthritis.PILRα对小鼠炎性关节炎起负向调节作用。
J Immunol. 2014 Jul 15;193(2):860-70. doi: 10.4049/jimmunol.1400045. Epub 2014 Jun 16.
Zotero 插件